...
首页> 外文期刊>Molecular Immunology >A tetravalent single chain diabody (CD40/HER2) efficiently inhibits tumor proliferation through recruitment of T cells and anti-HER2 functions
【24h】

A tetravalent single chain diabody (CD40/HER2) efficiently inhibits tumor proliferation through recruitment of T cells and anti-HER2 functions

机译:通过募集T细胞和抗HER2功能有效地抑制肿瘤增殖的四价单链(CD40 / HER2)

获取原文
获取原文并翻译 | 示例

摘要

Our aim was to construct a CD40 x HER2 single chain diabody (ScDb) and determine its tumor-specific immune activation and anti-HER2 function. Overlap extension-polymerase chain reaction was applied in the construction of ScDb, and the protein was expressed with the pET28a (+)-Rosetta prokaryotic expression system. Soluble ScDb was purified by a nickel-nitrilotriacetic acid column. Dendritic cells (DC) was stimulated by ScDb and inhibited 4T1 cells proliferation in vitro. In 4T1 tumor mice model, lymphocyte infiltration was prominently detected in ScDb group, Caspase-3 expression was significantly upregulated. ScDb was labeled using quantum dots. Immunofluorescence assay indicated ScDb exhibited high affinity to HER2. T6-17 cells were inhibited by ScDb in vitro. The phosphorylation and expression levels of AKT, ERK were markedly decreased. In T6.17 tumor mice model. Compared to CD40 ScFv, HER2 ScFv and normal saline groups, tumor volume diminished significantly in ScDb group, and tumor cells showed extensive deformation, and pervasive karyopyknosis and karyorrhexis were found. In the present study, we successfully constructed a ScDb fragment and expressed it using a prokaryotic expression system. The in vivo and in vitro experimental results indicated that ScDb could inhibit the proliferation of tumor cells by stimulating the tumor-specific immunoreaction and blocking the HER2-related signaling pathway.
机译:我们的目标是建造CD40 X Her2单链(SCDB),并确定其肿瘤特异性免疫激活和抗HER2功能。重叠延伸聚合酶链反应在SCDB的构建中施用,并且用PET28a(+) - 玫瑰花核苷酸原核表达系统表达蛋白质。通过镍氮酰基酰基酰基氨基纯化可溶性SCDB。通过SCDB刺激树突细胞(DC)并在体外抑制4T1细胞增殖。在4T1肿瘤小鼠模型中,在SCDB组中突出地检测到淋巴细胞浸润,Caspase-3表达显着上调。使用量子点标记SCDB。免疫荧光测定表明SCDB对HER2表现出高亲和力。通过体外SCDB抑制T6-17细胞。 Akt的磷酸化和表达水平显着降低。在T6.17肿瘤小鼠模型中。与CD40 SCFV,HER2 SCFV和生理盐水组,SCDB组中显着减少的肿瘤体积,肿瘤细胞显示出广泛的变形,并发现普遍的核心knopyknosis和Karyorrhexis。在本研究中,我们成功构建了SCDB片段并使用原核表达系统表示。体内和体外实验结果表明,SCDB通过刺激肿瘤特异性免疫反应并阻断HER2相关的信号通路来抑制肿瘤细胞的增殖。

著录项

  • 来源
    《Molecular Immunology》 |2019年第2019期|共8页
  • 作者单位

    Tianjin Med Univ Gen Hosp 154 Anshan Rd Tianjin 300052 Peoples R China;

    First Hosp Handan Dept Oncol Surg Handan Hebei Peoples R China;

    Tianjin Med Univ Gen Hosp 154 Anshan Rd Tianjin 300052 Peoples R China;

    Tianjin Med Univ Gen Hosp 154 Anshan Rd Tianjin 300052 Peoples R China;

    Tianjin Med Univ Gen Hosp 154 Anshan Rd Tianjin 300052 Peoples R China;

    Tianjin Med Univ Gen Hosp 154 Anshan Rd Tianjin 300052 Peoples R China;

    Tianjin Med Univ Gen Hosp 154 Anshan Rd Tianjin 300052 Peoples R China;

    Tianjin Med Univ Gen Hosp 154 Anshan Rd Tianjin 300052 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学免疫学;
  • 关键词

    CD40; HER2; Cancer; immunity; Single chain diabody; T cells;

    机译:CD40;HER2;癌症;免疫;单链架;T细胞;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号